The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Novel drug development opportunities for heparin
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
Rosenberg, R. D., & Damus, P. S. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43472-8 · Cited by 1,356
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Choay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Anticoagulant Action of Heparin
DAMUS, P. S., HICKS, M., & ROSENBERG, R. D. (1973) · Nature · doi:10.1038/246355a0 · Cited by 547
THE THROMBOPLASTIC ACTION OF CEPHALIN
McLean, J. (1916) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1916.41.2.250 · Cited by 530
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., & Parish, C. R. (1999) · Nature Medicine · doi:10.1038/10525 · Cited by 518
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
Lindahl, U., Bäckström, G., Thunberg, L., & Leder, I. G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6551 · Cited by 498
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., Eriksson, I., Ledin, J., Hellman, L., & Kjellén, L. (1999) · Nature · doi:10.1038/23488 · Cited by 481
Heparan sulfate: decoding a dynamic multifunctional cell regulator
Turnbull, J., Powell, A., & Guimond, S. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01897-3 · Cited by 474
Heparanase: a key enzyme involved in cell invasion
Parish, C. R., Freeman, C., & Hulett, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00017-8 · Cited by 466
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Bullock, S. L., Fletcher, J. M., Beddington, R. S. P., & Wilson, V. A. (1998) · Genes & Development · doi:10.1101/gad.12.12.1894 · Cited by 455
Heparin is essential for the storage of specific granule proteases in mast cells
Humphries, D. E., Wong, G. W., Friend, D. S., Gurish, M. F., Qiu, W.-T., Huang, C., Sharpe, A. H., & Stevens, R. L. (1999) · Nature · doi:10.1038/23481 · Cited by 428
Koenig, A., Norgard-Sumnicht, K., Linhardt, R., & Varki, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1509 · Cited by 403
Parish, C. R., Freeman, C. G., Brown, K. J., Francis, D. J., & Cowden, W. B. (1999) · PubMed · Cited by 400
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement
Turpie, A. G. G., Gallus, A. S., & Hoek, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440901 · Cited by 380
Extension and structural variability of the antithrombin-binding sequence in heparin.
Lindahl, U., Thunberg, L., Bäckström, G., Riesenfeld, J., Nordling, K., & Björk, I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90755-6 · Cited by 340
Synthesis of thrombin-inhibiting heparin mimetics without side effects
Petitou, M., Hérault, J.-P., Bernat, A., Driguez, P.-A., Duchaussoy, P., Lormeau, J.-C., & Herbert, J.-M. (1999) · Nature · doi:10.1038/18877 · Cited by 326
Heparanases and tumor metastasis
Nakajima, M., Irimura, T., & Nicolson, G. L. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360207 · Cited by 305
Vlodavsky, I., Eldor, A., Haimovitz‐Friedman, A., Matzner, Y., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I. R., & FUKS, Z. Y. (1992) · PubMed · Cited by 302
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).
Diamond, M. S., Alon, R., Parkos, C. A., Quinn, M. T., & Springer, T. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.6.1473 · Cited by 279
Substrate Specificity of Heparanases from Human Hepatoma and Platelets
Pikas, D. S., Li, J.-P., Vlodavsky, I., & Lindahl, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18770 · Cited by 261
Biochemical and Molecular Aspects of the Coagulation Cascade
Davie, E. W. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642645 · Cited by 256
Heparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation
Tyrrell, D. J., Horne, A. P., Holme, K. R., Preuss, J. M. H., & Page, C. P. (1999) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60471-8 · Cited by 245
Self-citationBladder-Surface Glycosaminoglycans: An Efficient Mechanism of Environmental Adaptation
Parsons, C. L., Stauffer, C., & Schmidt, J. D. (1980) · Science · doi:10.1126/science.6154316 · Cited by 235
Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin
Ahmed, T., Garrigo, J., & Danta, I. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290204 · Cited by 218
Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson, A.-M., Kjellén, L., & Forsberg, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000359200 · Cited by 217
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
Hettiarachchi, R., Smorenburg, S., Ginsberg, J., Levine, M., Prins, M., & Büller, H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615937 · Cited by 206
Processing of the Human Heparanase Precursor and Evidence That the Active Enzyme Is a Heterodimer
Fairbanks, M. B., Mildner, A. M., Leone, J. W., Cavey, G. S., Mathews, W. R., Drong, R. F., Slightom, J. L., Bienkowski, M. J., Smith, C. W., Bannow, C. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29587 · Cited by 198
GMP-140 binding to neutrophils is inhibited by sulfated glycans.
Skinner, M. P., Lucas, C. M., Burns, G. F., Chesterman, C. N., & Berndt, M. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67603-9 · Cited by 197
Cloning and Expression Profiling of Hpa2, a Novel Mammalian Heparanase Family Member
McKenzie, E., Tyson, K., Stamps, A., Smith, P., Turner, P., Barry, R., Hircock, M., Patel, S., Barry, E., Stubberfield, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3586 · Cited by 193
Paradoxical response to heparin in 10 patients with ulcerative colitis.
Gaffney, P. R., Doyle, C. T., Gaffney, A., Hogan, J., Hayes, D. P., & Annis, P. (1995) · PubMed · Cited by 189
Lider, O., Baharav, E., Mekori, Y. A., Miller, T., Naparstek, Y., Vlodavsky, I., & Cohen, I. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113953 · Cited by 189
Lundin, L., Larsson, H., Kreuger, J., Kanda, S., Lindahl, U., Salmivirta, M., & Claesson-Welsh, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908930199 · Cited by 177
Disruption of sulphated glycosaminoglycans in intestinal inflammation
Murch, S. H., MacDonald, T. T., Walker-Smith, J. A., Lionetti, P., Levin, M., & Klein, N. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90485-y · Cited by 170
Watt, S., Williamson, J., Genevier, H., Fawcett, J., Simmons, D., Hatzfeld, A., Nesbitt, S., & Coombe, D. (1993) · Blood · doi:10.1182/blood.v82.9.2649.2649 · Cited by 158
Lider, O., Mekori, Y. A., Miller, T. B., et al. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200306 · Cited by 153
Identification of Active-Site Residues of the Pro-Metastatic Endoglycosidase Heparanase
Hulett, M. D., Hornby, J. R., Ohms, S., Zuegg, J., Freeman, C. G., Gready, J. E., & Parish, C. R. (2000) · Biochemistry · doi:10.1021/bi002080p · Cited by 152
Bar-Ner, M., Eldor, A., Wasserman, L., et al. (1987) · Blood · doi:10.1182/blood.v70.2.551.551 · Cited by 151
Klein, N. J., Shennan, G. I., Heyderman, R. S., & Levin, M. (1992) · Journal of Cell Science · doi:10.1242/jcs.102.4.821 · Cited by 149
Zacharski, L. R., & Ornstein, D. L. (1998) · PubMed · Cited by 149
Diamant, Z., Timmers, M., van der Veen, H., Page, C. P., van der Meer, F. J., & Sterk, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665036 · Cited by 138
Self-citationHeparin Inhibits the Immediate Response to Antigen in the Skin and Lungs of Allergic Subjects
Bowler, S., Smith, S. M. S., & Lavercombe, P. S. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.1.160 · Cited by 131
Oral Delivery of Anticoagulant Doses of Heparin
Baughman, R., Kapoor, S. C., Agarwal, R., Kisicki, J. C., Catella-Lawson, F., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.16.1610 · Cited by 129
Giuffrè, L., Cordey, A.-S., Monai, N., Tardy, Y., Schapira, M., & Spertini, O. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.4.945 · Cited by 122
Actions of heparin that may affect the malignant process
Engelberg, H. (1999) · Cancer · Cited by 117
Lee, Y.-K., Nam, J. H., Shin, H., & Byun, Y. (2001) · Circulation · doi:10.1161/hc5001.100627 · Cited by 115
Lever, R., Hoult, J. R. S., & Page, C. P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703099 · Cited by 108
Self-citationInhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides
Tangelder, G., & Arfors, K. (1991) · Blood · doi:10.1182/blood.v77.7.1565.1565 · Cited by 88
Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity
Sy, M. S., Schneeberger, E. E., McCluskey, R., Greene, M. I., ROSENBERG, R. D., & D, B. B. M. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90137-5 · Cited by 85
Fath, M. A., Wu, X., Hileman, R. E., Linhardt, R. J., Kashem, M. A., Nelson, R. M., Wright, C. D., & Abraham, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13563 · Cited by 85
Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides.
Willenborg, D. O., & Parish, C. R. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3401 · Cited by 72
Sciumbata, T., Caretto, P., Pirovano, P., et al. (1996) · PubMed · Cited by 51
Lung Deposition and Clearance of Inhaled 99mTc-Heparin in Healthy Volunteers
Bendstrup, K. E., Chambers, C. B., Jensen, J. I., & Newhouse, M. T. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9809123 · Cited by 49
Teixeira, M. M., & Hellewell, P. G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13991.x · Cited by 47
Xie, X., Thorlacius, H., Raud, J., Hedqvist, P., & Lindbom, L. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701454 · Cited by 41
McLeskey, S. W., Zhang, L., Trock, B. J., Kharbanda, S., Liu, Y., Gottardis, M. M., Lippman, M. E., & Kern, F. G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.204 · Cited by 41
Development of Oral Heparin Therapy for Prophylaxis and Treatment of Deep Venous Thrombosis
Money, S., & York, J. W. (2001) · Cardiovascular Surgery · doi:10.1177/096721090100900302 · Cited by 40
Smailbegovic, A., Lever, R., & Page, C. P. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704321 · Cited by 32
Self-citationOptimal Timing of Hemodilution for Brain Protection in a Canine Model of Focal Cerebral Ischemia
Yanaka, K., Camarata, P. J., Spellman, S. R., McDonald, D. E., & Heros, R. C. (1996) · Stroke · doi:10.1161/01.str.27.5.906 · Cited by 32
Antithrombotic Activity of Oral Unfractionated Heparin
Hiebert, L. M., Wice, S. M., & Jaques, L. B. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199607000-00005 · Cited by 31
Hiebert, L. M., Wice, S. M., Ping, T., Hileman, R. E., Capila, I., & Linhardt, R. J. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-4-307 · Cited by 22
Hiebert, L. M., Wice, S. M., Ping, T., Hileman, R. E., Capila, I., & Linhardt, R. J. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-140 · Cited by 13
Cited by
Complexity in biomaterials for tissue engineering
Place, E. S., Evans, N. D., & Stevens, M. M. (2009) · Nature Materials · doi:10.1038/nmat2441 · Cited by 1,728
Chemokine:Receptor Structure, Interactions, and Antagonism
Allen, S. J., Crown, S. E., & Handel, T. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090529 · Cited by 839
The Platelet Lifeline to Cancer: Challenges and Opportunities
Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V., & Sood, A. K. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.002 · Cited by 638
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 508
Metadata
- Authors
- Lever, R., & Page, C. P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-02
- Volume
- 1
- Issue
- 2
- Pages
- 140-148
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2044490764
- Cited by
- 328
- References
- 67
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.